Heat Biologics: Falls on plans to raise $18 mln in equity

Scorpius Holdings

04/04/2019 12:37

** Cancer drug developer's shares  HTBX.O  fall 4.1 pct to
$1.18 in premarket after company announces plans to raise up to
$18 mln in equity
    ** Co enters a market issuance sales agreement with B Riley
to sell https://www.sec.gov/Archives/edgar/data/1476963/000155335019000326/htbx_8k.htm
 its shares
    ** HTBX has market value of $40.7 mln, per Refinitiv data
    ** Stock has risen 25 pct this year

 (Reporting by Amy Caren Daniel in Bengaluru)
 ((Reuters Messaging:
Amy.CarenDaniel.thomsonreuters.com@reuters.net))